These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 39268157)

  • 1. [Retracted] miR‑148a‑3p suppresses epithelial ovarian cancer progression primarily by targeting c‑Met.
    Wang W; Dong J; Wang M; Yao S; Tian X; Cui X; Fu S; Zhang S
    Oncol Lett; 2024 Nov; 28(5):511. PubMed ID: 39268157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Retracted] miR‑143‑5p suppresses breast cancer progression by targeting the HIF‑1α‑related GLUT1 pathway.
    Xu J; Li X; Zhang P; Luo J; Mou E; Liu S
    Oncol Lett; 2024 Jul; 28(1):311. PubMed ID: 38784604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Retracted] MicroRNA‑454‑3p inhibits cervical cancer cell invasion and migration by targeting c‑Met.
    Guo Y; Tao M; Jiang M
    Exp Ther Med; 2024 May; 27(5):179. PubMed ID: 38515649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Retracted] MicroRNA‑139‑5p inhibits cell viability, migration and invasion and suppresses tumor growth by targeting HDGF in non‑small cell lung cancer.
    Zhang Z; Li W; Jiang D; Liu C; Lai Z
    Oncol Lett; 2023 Dec; 26(6):503. PubMed ID: 37920439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Retracted] MicroRNA‑30a suppresses the proliferation, migration and invasion of human renal cell carcinoma cells by directly targeting ADAM9.
    Jiang L; Liu Y; Ma C; Li B
    Oncol Lett; 2024 Mar; 27(3):100. PubMed ID: 38298431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Retracted] MicroRNA‑126 exerts antitumor functions in ovarian cancer by targeting EGFL7 and affecting epithelial‑to‑mesenchymal transition and ERK/MAPK signaling pathway.
    Zhang Y; Qin X; Jiang J; Zhao W
    Oncol Lett; 2024 Sep; 28(3):415. PubMed ID: 38988446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retracted: MiR-1270 Suppresses the Malignant Progression of Breast Cancer via Targeting MMD2.
    Healthcare Engineering JO
    J Healthc Eng; 2023; 2023():9843621. PubMed ID: 37564800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Retracted] Exosomal miR‑130a‑3p promotes the progression of differentiated thyroid cancer by targeting insulin‑like growth factor 1.
    Yin G; Kong W; Zheng S; Shan Y; Zhang J; Ying R; Wu H
    Oncol Lett; 2023 Oct; 26(4):430. PubMed ID: 37664654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Retracted] Ursolic acid suppresses the biological function of osteosarcoma cells.
    Pei Y; Zhang Y; Zheng K; Shang G; Wang Y; Wang W; Qiu E; Zhang X
    Oncol Lett; 2023 Jul; 26(1):316. PubMed ID: 37332330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retracted: DDTC Suppresses Ovarian Cancer Development via the PI3K/AKT/mTOR Signaling Pathway.
    Markers D
    Dis Markers; 2023; 2023():9810565. PubMed ID: 37502573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Retracted] MicroRNA‑19b promotes the migration and invasion of ovarian cancer cells by inhibiting the PTEN/AKT signaling pathway.
    Liu DT; Yao HR; Li YY; Song YY; Su MY
    Oncol Lett; 2024 Jul; 28(1):291. PubMed ID: 38737979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ovarian cancer ascites enhance the migration of patient-derived peritoneal mesothelial cells via cMet pathway through HGF-dependent and -independent mechanisms.
    Matte I; Lane D; Laplante C; Garde-Granger P; Rancourt C; Piché A
    Int J Cancer; 2015 Jul; 137(2):289-98. PubMed ID: 25482018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR‑148a‑3p regulates alcoholic liver fibrosis through targeting ERBB3.
    Xiong J; Ni J; Chen C; Wang K
    Int J Mol Med; 2020 Sep; 46(3):1003-1012. PubMed ID: 32582976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Retracted] ATP‑binding cassette transporter A7 accelerates epithelial‑to‑mesenchymal transition in ovarian cancer cells by upregulating the transforming growth factor‑β signaling pathway.
    Liu X; Li Q; Zhou J; Zhang S
    Oncol Lett; 2024 Aug; 28(2):353. PubMed ID: 38872857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Retracted] Downregulation of thymopoietin by miR‑139‑5p suppresses cell proliferation and induces cell cycle arrest/apoptosis in pancreatic ductal adenocarcinoma.
    Zhou H; Zhang L; Tu H
    Oncol Lett; 2024 Oct; 28(4):490. PubMed ID: 39185488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Retracted] MicroRNA‑574‑3p inhibits the malignant behavior of liver cancer cells by targeting ADAM28.
    Zha Z; Jia F; Hu P; Mai E; Lei T
    Oncol Lett; 2023 Sep; 26(3):387. PubMed ID: 37559579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Retracted] MicroRNA‑195 inhibits the behavior of cervical cancer tumors by directly targeting HDGF.
    Song R; Cong L; Ni G; Chen M; Sun H; Sun Y; Chen M
    Oncol Lett; 2024 Oct; 28(4):464. PubMed ID: 39119232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retracted: MicroRNA-139-5p Suppresses Cell Malignant Behaviors in Breast Cancer through Targeting MEX3A.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9850272. PubMed ID: 37811289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting of KDM5A by miR-421 in Human Ovarian Cancer Suppresses the Progression of Ovarian Cancer Cells [Retraction].
    Onco Targets Ther; 2024; 17():359-360. PubMed ID: 38650606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Retracted] Downregulation of miR‑30a is associated with proliferation and invasion via targeting MEF2D in cervical cancer.
    Zhao J; Li B; Shu C; Ma Y; Gong Y
    Oncol Lett; 2024 Jan; 27(1):35. PubMed ID: 38108077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.